These multifaceted roles that CDKN1A/p21 play in cell cycle control within the nucleus make it an intriguing target for cancer therapy; however, the various mechanisms of its action and regulation require further global gene expression, chromatin binding, and pathway analysis to facilitate more sophisticated drug development approaches. The gene discussed is CDKN1A; the disease is cancer.